![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1642801
Àå±â º¸Á¸ ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, ¿¹Ãø - º¸Á¸ ¼Ö·ç¼Çº°, Àå±â Á¦°ø À¯Çüº°, ¼ö¹ýº°, Àå±â À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°(2025-2033³â)Organ Preservation Market Size, Share, Trends and Forecast by Preservation Solution, Organ Donation Type, Technique, Organ Type, End-User, and Region, 2025-2033 |
¼¼°èÀÇ Àå±â º¸Á¸ ½ÃÀå ±Ô¸ð´Â 2024³â 1¾ï 9,887¸¸ ´Þ·¯°¡ µÆ½À´Ï´Ù. IMARC GroupÀº ÇâÈÄ ½ÃÀåÀÌ 2033³â±îÁö 3¾ï 2,040¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, 2025³âºÎÅÍ 2033³â±îÁö 5.39%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ÇöÀç ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ´Â °ÍÀº ºÏ¹ÌÀ̸ç, 2024³â ½ÃÀå Á¡À¯À²Àº 45.9%¸¦ ³Ñ¾ú½À´Ï´Ù. ºÏ¹ÌÀÇ ¼ºÀå ¿øµ¿·ÂÀº ÷´Ü °Ç° °ü¸® ÀÎÇÁ¶ó, Àå±â ÀÌ½Ä Áõ°¡, ±â¼ú Áøº¸, Á¤ºÎÀÇ Áö¿øÃ¥ÀÔ´Ï´Ù.
Àå±â º¸Á¸À̶õ ±âÁõÀÚÀÇ Ã¼³»¿¡¼ äÃëÇÑ °Ç°ÇÑ Àå±â¸¦ º¸Á¸ÇÏ´Â °úÁ¤À» ¸»ÇÕ´Ï´Ù. ÀÌ °úÁ¤¿¡¼ ±âÁõÀÚÀÇ Ã¼³»¿¡¼ Àå±â¸¦ Á¦°ÅÇÏ°í ¿î¼ÛÀ» À§ÇØ º¸°üÇÑ ÈÄ, Å« ¼Õ»óÀ» ÁÖÁö ¾ÊÀ¸¸é¼ ¼ö·ÉÀÎÀÇ Ã¼³»¿¡ À̽ÄÇÕ´Ï´Ù. ½ÅÀå, °£, Æó, ½ÉÀå ¹× ±âŸ Àå±âÀÇ ¿Âµµ¿Í »ê¼Ò ¼öÁØÀ» À¯ÁöÇϱâ À§ÇØ Àúü¿Â ±â°è °ü·ù, Á¤Àû Àú¿Â º¸Á¸(SCS), Á¤»ó ü¿Â ±â°è °ü·ù(NMP) µî ´Ù¾çÇÑ ±â¼úÀÌ »ç¿ëµË´Ï´Ù. »ç¿ëµÇ´Â º¸Á¸ ±â¼ú°ú ¿ë¾×Àº ÀÌ½Ä ÈÄ È¯ÀÚÀÇ ÀÌȯÀ²°ú »ýÁ¸À²¿¡ Á÷Á¢ ¿µÇâÀ» ¹ÌÄ¡´Â ±âÁõÀÚ Àå±âÀÇ Ç°Áú¿¡ ÇʼöÀûÀÔ´Ï´Ù.
¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼¼°è ³ëÀÎ Àα¸ Áõ°¡¿Í ÇÔ²² ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ´ç´¢º´, ½ÉÇ÷°ü Àå¾Ö(CVDs), ºñ¸¸ ¹× ±âŸ ½É°¢ÇÑ º´¸®·Î ÀÎÇØ Àå±â ºÎÀüÀÌ ÀÚÁÖ ¹ß»ýÇϱ⠶§¹®¿¡ Àå±â ¿ÂÁ¸ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. Àå±â º¸Á¸À» À§ÇÑ NMP¿Í °°Àº Çõ½ÅÀûÀÌ°í °í±Þ ±â¼úÀÇ ÃâÇöÀº ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ÀÌ½Ä Áß Àç°ü·ù Àå¾ÖÀÇ È®·üÀ» °¨¼Ò½ÃŰ´Â µ¥ µµ¿òÀÌ µÇ¾úÀ¸¸ç ÀÓ»ó ¹× ½ÇÇèÀû ¿¬±¸¸¦ À§ÇÑ Àú¿Â º¸Á¸¿¡¼ °³¼±µÈ °á°ú¸¦ º¸¿©ÁÝ´Ï´Ù. ¶ÇÇÑ Àå±â Á¦°øÀ» ÃËÁøÇÏ´Â Á¤ºÎ ¹× ºñÁ¤ºÎ Á¤Ã¥°ú ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡°¡ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤Àû ¿µÇâÀ» ¹ÌĨ´Ï´Ù. À̽ÄÀ̳ª ¿¬±¸ ¸ñÀûÀ¸·Î Àå±â Á¦°øÀ» Áö¿øÇÏ´Â °³ÀÎ Áõ°¡µµ ½ÃÀåÀ» ´õ¿í °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ß(R&D)ÀÇ °È³ª Àå±âº¸Á¸ ÀÎÇÁ¶óÀÇ ´ëÆøÀûÀÎ Áøº¸ µî ±âŸ ¿äÀεµ ½ÃÀå ¼ºÀå¿¡ Å©°Ô °øÇåÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.
The global organ preservation market size was valued at USD 198.87 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 320.40 Million by 2033, exhibiting a CAGR of 5.39% from 2025-2033. North America currently dominates the market, holding a market share of over 45.9% in 2024. The growth of the North American region is driven by advanced healthcare infrastructure, rising organ transplants, technological advancements, and supportive government initiatives.
Organ preservation refers to the process of preserving healthy organs harvested from the body of donors. The process involves the removal of organs from the donor's body, storing it for transportation and then transplanting it into the receiver's body without significant damage. It utilizes various techniques, such as hypothermic machine perfusion, static cold storage (SCS) and normothermic machine perfusion (NMP), to maintain the temperature and oxygen levels of kidneys, liver, lung, heart and other organs. The preservation techniques and solutions used are essential for donor organ quality, which directly influences the morbidity and survival rates of a patient after transplantation.
The increasing prevalence of chronic diseases, along with the growing geriatric population across the globe, are among the key factors driving the growth of the market. Owing to the frequent occurrences of organ failures due to diabetes, cardiovascular disorders (CVDs), obesity, and other such severe medical conditions, there is an increasing need for organ preservation procedures. The advent of innovative and advanced techniques, such as NMP, for organ preservation, is acting as a growth-inducing factor. Such techniques aid in decreasing the probability of reperfusion injury during transplantation and exhibits improved results in cold storage for clinical and experimental studies. Moreover, an increasing number of government and non-government policies and initiatives to promote organ donation are impacting the market growth positively. The rising number of individuals volunteering to donate their organs for transplantation and research purposes are also driving the market further. Other factors, including enhanced research and development (R&D) and significant advancements in the organ preservation infrastructure, are also projected to contribute to the market growth significantly.
UW Solution
Custodiol HTK
Perfadex
Others
Living Organ Donation
Deceased Organ Donation
Static Cold Storage Technique
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
Kidney
Liver
Lung
Heart
Others
Hospitals and Clinics
Organ Banks
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being 21st Century Medicine, Biolife Solutions, Bridge to Life Ltd., Bristol-Myers Squibb, Dr. Franz Kohler Chemie GmbH, Essential Pharmaceuticals., Lifeline Scientific, OrganOx, Paragonix Technologies, TransMedics, Waters Medical Systems, Xvivo Perfusion, etc.